Specific keynote: molecular therapeutics in ovarian cancer.
Mills
Gordon B
GB
University of Texas M. D. Anderson Cancer Center, USA.
Fang
Xianjun
X
Lu
Yiling
Y
Hasegawa
Yutaka
Y
Eder
Astrid
A
Tanyi
Janos
J
Tabassam
Fazad Haq
FH
Mao
Muling
M
Wang
Hongwei
H
Cheng
Kwai Wa
KW
Nakayama
Yasuhisa
Y
Kuo
Wenlin
W
Erickson
Jim
J
Gershenson
David
D
Kohn
Elise C
EC
Jaffe
Robert
R
Bast
Robert C
RC
Gray
Joe
J
D002893:Chromosomes, Human, Pair 3; D005260:Female; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D008246:Lysophospholipids / Q000096:biosynthesis / Q000235:genetics; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000628:therapy*; D019869:Phosphatidylinositol 3-Kinases / Q000235:genetics; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011956:Receptors, Cell Surface / Q000096:biosynthesis / Q000235:genetics; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid
D008246:Lysophospholipids; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid